Pubblicazioni

Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life study

2021 - EXPERT OPINION ON DRUG SAFETY

Pugliese, N.; Giorgini, A.; Maggi, D.; Capogreco, A.; Dibenedetto, C.; Lubrano Lobianco, F.; Dal Buono, A.; Monico, S.; Meli, R.; Battezzati, P. M.; Lleo, A.; De Santis, A.; Zuin, M.; Aghemo, A.

Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients: Evidence from the PITER Real-World Cohort

2018 - VALUE IN HEALTH

Ruggeri, M.; Coretti, S.; Romano, F.; Kondili, L. A.; Vella, S.; Cicchetti, A.

Virological and clinical response to interferon-free regimens in patients with HCV-related mixed cryoglobulinemia: Preliminary results of a prospective pilot study

2017 - CURRENT DRUG TARGETS

Gragnani, Laura; Piluso, Alessia; Urraro, Teresa; Fabbrizzi, Alessio; Fognani, Elisa; Petraccia, Luisa; Genovesi, Alessandro; Giubilei, Lidia; Ranieri, Jessica; Stasi, Cristina; Monti, Monica; Zignego, Anna Linda

Recipient female gender is a risk factor for graft loss after liver transplantation for chronic hepatitis C: Evidence from the prospective Liver Match cohort

2015 - DIGESTIVE AND LIVER DISEASE

Belli, Luca Saverio; Romagnoli, Renato; Nardi, Alessandra; Marianelli, Tania; Donato, Francesca; Corradini, Stefano Ginanni; Iemmolo, Rosa Maria; Morelli, Cristina; Pasulo, Luisa; Rendina, Maria; De Martin, Eleonora; Ponziani, Francesca Romana; Volpes, Riccardo; Strazzabosco, Mario; Angelico, Mario